Fisioterapia na prevenção e tratamento das complicações do membro superior em mulheres com câncer de mama

Conteúdo do artigo principal

Taynara Louisi Pilger
https://orcid.org/0000-0003-2622-2819
Anna Julia Matheus Ortolani
https://orcid.org/0000-0003-3284-3777
Francisco José Candido dos Reis Reis
https://orcid.org/0000-0001-5758-5917

Resumo

O câncer de mama é o que mais acomete a população feminina no Brasil e no mundo. Complicações do membro superior são comuns após o tratamento oncológico, inclusive em procedimentos conservadores. Estudos antigos já mostravam a eficácia da fisioterapia na reabilitação dessas complicações, contudo, atualmente a atenção fisioterapêutica deve ser iniciada a partir do diagnóstico da doença. A pré-reabilitação prepara a paciente para receber o tratamento oncológico e promove diminuição do tempo de reabilitação. A reabilitação diminuiu o cordão axilar em 57%, aumentou a amplitude de movimento (ADM) em 45º para flexão e 70º para abdução de ombro, a incidência de linfedema é de 11% e há diminuição de 3.4 pontos em relação a dor na Escala Visual Analógica (EVA). O fisioterapeuta deve atuar no câncer de mama no diagnóstico, prevenção e reabilitação pós-tratamento oncológico, promovendo funcionalidade e qualidade de vida para as pacientes com câncer de mama.



Detalhes do artigo

Como Citar
1.
Pilger TL, Ortolani AJM, Reis FJC dos R. Fisioterapia na prevenção e tratamento das complicações do membro superior em mulheres com câncer de mama . Health Sci J [Internet]. 28º de junho de 2022 [citado 11º de maio de 2024];12(2):3-11. Disponível em: https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1249
Seção
REVISÃO NARRATIVA
Biografia do Autor

Taynara Louisi Pilger, Faculdade de Medicina de Ribeirão Preto

Doutoranda em Ginecologia e Obstetrícia pela Faculdade de Medicina de Ribeirão Preto.

Anna Julia Matheus Ortolani, Faculdade de Medicina de Ribeirão Preto

Acadêmica do 2º ano de Fisioterapia da Faculdade de Medicina de Ribeirão Preto.

Francisco José Candido dos Reis Reis, Faculdade de Medicina de Ribeirão Preto

Mestrado (1997) e Doutorado (1999) em Ginecologia e Obstetrícia na Universidade de São Paulo (FMRP-USP). Pós-doutorado no Brigham and Womens Hospital na Harvard Medical School em Boston (2004-2005) e Pesquisador Visitante no Centre for Cancer Genetic Epidemiology na Universidade de Cambridge no Reino Unido (2013-2015). É professor associado (nível III) da FMRP-USP.

Referências

1. INCA. Estimativa 2020: incidência de câncer no Brasil [Internet]. INCA - Instituto Nacional de Câncer. 2019 [updated 2020 Apr 29; cited 2022 Jun 1]. Available from: https://www.inca.gov.br/publicacoes/livros/estimativa-2020-incidencia-de-cancer-no-brasil
2. World Health Organization. Cancer today [Internet]. Data visualization tools for exploring the global cancer burden in 2020 [cited 2022 Jun 1]. Available from: http://gco.iarc.fr/today/home
3. Peto R, Boreham J, Clarke M, Davies C, Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet. 2000;355(9217):1822. https://doi.org/10.1016/S0140-6736(00)02277-7
4. Pilger TL, Francisco DF, Candido Dos Reis FJ. Effect of sentinel lymph node biopsy on upper limb function in women with early breast cancer: A systematic review of clinical trials. Eur J Surg Oncol. 2021;47(7):1497-506. https://doi.org/10.1016/j.ejso.2021.01.024
5. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233-41. https://doi.org/10.1056/NEJMoa022152
6. Le Dran HF, Académie royale de chirurgie (France). Mémoire avec un précis de plusieurs observations sur le cancer [Book]. Paris: [publisher not identified]; 1757.
7. Qiu SQ, Zhang GJ, Jansen L, de Vries J, Schröder CP, de Vries EGE, et al. Evolution in sentinel lymph node biopsy in breast cancer. Crit Rev Oncol Hematol. 2018;123:83-94. https://doi.org/10.1016/j.critrevonc.2017.09.010
8. Castaneda SA, Strasser J. Updates in the treatment of breast cancer with radiotherapy. Surg Oncol Clin N Am. 2017;26(3):371-82. https://doi.org/10.1016/j.soc.2017.01.013
9. Vugts G, Maaskant-Braat AJG, Nieuwenhuijzen GAP, Roumen RMH, Luiten EJT, Voogd AC. Patterns of care in the administration of neo-adjuvant chemotherapy for breast cancer. A population-based study. Breast J. 2016;22(3):316-21. https://doi.org/10.1111/tbj.12568
10. Chrischilles EA, Riley D, Letuchy E, Koehler L, Neuner J, Jernigan C, et al. Upper extremity disability and quality of life after breast cancer treatment in the Greater Plains Collaborative clinical research network. Breast Cancer Res Treat. 2019;175(3):675-89. https://doi.org/10.1007/s10549-019-05184-1
11. Lee TS, Kilbreath SL, Refshauge KM, Herbert RD, Beith JM. Prognosis of the upper limb following surgery and radiation for breast cancer. Breast Cancer Res Treat. 2008;110(1):19-37. https://doi.org/10.1007/s10549-007-9710-9
12. Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM, et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010;102(2):111-8. https://doi.org/10.1002/jso.21535
13. DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500-15. https://doi.org/10.1016/S1470-2045(13)70076-7
14. Shah C, Vicini FA. Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies. Int J Radiat Oncol Biol Phys. 2011;81(4):907-14. https://doi.org/10.1016/j.ijrobp.2011.05.043
15. Shaitelman SF, Chiang YJ, Griffin KD, DeSnyder SM, Smith BD, Schaverien MV, et al. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis. Breast Cancer Res Treat. 2017;162(2):201-15. https://doi.org/10.1007/s10549-016-4089-0
16. Ugur S, Arıcı C, Yaprak M, Mescı A, Arıcı GA, Dolay K, et al. Risk factors of breast cancer-related lymphedema. Lymphat Res Biol. 2013;11(2):72-5. https://doi.org/10.1089/lrb.2013.0004
17. Soyder A, Taştaban E, Özbaş S, Boylu Ş, Özgün H. Frequency of early-stage lymphedema and risk factors in postoperative patients with breast cancer. J Breast Health. 2014;10(2):92-7. https://doi.org/10.5152/tjbh.2014.1973
18. Langford DJ, Schmidt B, Levine JD, Abrams G, Elboim C, Esserman L, et al. Preoperative breast pain predicts persistent breast pain and disability after breast cancer surgery. J Pain Symptom Manage. 2015;49(6):981-94. https://doi.org/10.1016/j.jpainsymman.2014.11.292
19. Gärtner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302(18):1985-92. https://doi.org/10.1001/jama.2009.1568
20. Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. 2011;12(7):725-46. https://doi.org/10.1016/j.jpain.2010.12.005
21. Leysen L, Beckwée D, Nijs J, Pas R, Bilterys T, Vermeir S, et al. Risk factors of pain in breast cancer survivors: a systematic review and meta-analysis. Support Care Cancer. 2017;25(12):3607-43. https://doi.org/10.1007/s00520-017-3824-3
22. Santos MSMD, Panobianco MS, Mamede MV, Meirelles MCCC, Barros VME. [Tactile sensibility in arm of women subjected to the axillary lymph node dissection for breast cancer]. Rev Bras Ginecol Obstet. 2009;31(7):361-6. https://doi.org/10.1590/S0100-72032009000700007
23. Bezerra TS, Rett MT, Mendonça ACR, Santos DE, Prado VM, DeSantana JM. Hipoestesia, dor e incapacidade no membro superior após radioterapia adjuvante no tratamento para câncer de mama. Rev dor. dezembro de 2012;13:320-6. https://doi.org/10.1590/S1806-00132012000400003
24. Blomqvist L, Stark B, Engler N, Malm M. Evaluation of arm and shoulder mobility and strength after modified radical mastectomy and radiotherapy. Acta Oncol. 2004;43(3):280-3. https://doi.org/10.1080/02841860410026170
25. Pillai US, Kayal S, Cyriac S, Nisha Y, Dharanipragada K, Kamalanathan SK, et al. Late Effects of Breast Cancer Treatment and Outcome after Corrective Interventions. Asian Pac J Cancer Prev. 2019;20(9):2673-9.
https://doi.org/10.31557/APJCP.2019.20.9.2673
26. Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat. 2016;159(2):327-33. https://doi.org/10.1007/s10549-016-3939-0
27. Fougo JL, Dinis-Ribeiro M, Araújo C, Dias T, Reis P, Giesteira L, et al. Impacto de la linfadenectomía sobre la recurrencia axilar y la morbilidad del miembro superior en pacientes con cáncer de mama y ganglio centinela negativo: Estudio prospectivo aleatorizado. Cir Esp. 2011;89(5):307-16. Spanish. https://doi.org/10.1016/j.ciresp.2011.01.011
28. Yang S, Park DH, Ahn SH, Kim J, Lee JW, Han JY, et al. Prevalence and risk factors of adhesive capsulitis of the shoulder after breast cancer treatment. Support Care Cancer. 2017;25(4):1317-22. https://doi.org/10.1007/s00520-016-3532-4
29. Silver JK, Baima J. Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. Am J Phys Med Rehabil. 2013;92(8):715-27. https://doi.org/10.1097/PHM.0b013e31829b4afe
30. Campbell KL, Pusic AL, Zucker DS, McNeely ML, Binkley JM, Cheville AL, et al. A prospective model of care for breast cancer rehabilitation: function. Cancer. 2012;118(8 Suppl):2300-11. https://doi.org/10.1002/cncr.27464
31. Nilsson H, Angerås U, Bock D, Börjesson M, Onerup A, Fagevik Olsen M, et al. Is preoperative physical activity related to post-surgery recovery? A cohort study of patients with breast cancer. BMJ Open. 2016;6(1):e007997. https://doi.org/10.1136/bmjopen-2015-007997
32. Torres Lacomba M, Yuste Sánchez MJ, Zapico Goñi A, Prieto Merino D, Mayoral del Moral O, Cerezo Téllez E, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ. 2010;340:b5396. https://doi.org/10.1136/bmj.b5396
33. Lu SR, Hong RB, Chou W, Hsiao PC. Role of physiotherapy and patient education in lymphedema control following breast cancer surgery. Ther Clin Risk Manag. 2015;11:319-27. https://doi.org/10.2147/TCRM.S77669
34. Stanton AW, Badger C, Sitzia J. Non-invasive assessment of the lymphedematous limb. Lymphology. 2000;33(3):122-35. PMID: 11019400
35. Chen YW, Tsai HJ, Hung HC, Tsauo JY. Reliability study of measurements for lymphedema in breast cancer patients. Am J Phys Med Rehabil. 2008;87(1):33-8. https://doi.org/10.1097/PHM.0b013e31815b6199
36. Scrimshaw SV, Maher C. Responsiveness of visual analogue and McGill pain scale measures. J Manipulative Physiol Ther. 2001;24(8):501-4. https://doi.org/10.1067/mmt.2001.118208
37. Suda M, Kawakami M, Okuyama K, Ishii R, Oshima O, Hijikata N, et al. Validity and Reliability of the Semmes-Weinstein Monofilament Test and the Thumb Localizing Test in patients with stroke. Front Neurol. 2021;11:625917. https://doi.org/10.3389/fneur.2020.625917
38. Gandbhir VN, Cunha B. Goniometer. [Updated 2021 Jun 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK558985
39. Cronin J, Lawton T, Harris N, Kilding A, McMaster DT. A Brief review of handgrip strength and sport performance. J Strength Cond Res. 2017;31(11):3187-217. https://doi.org/10.1519/JSC.0000000000002149
40. Gordon LG, Battistutta D, Scuffham P, Tweeddale M, Newman B. The impact of rehabilitation support services on health-related quality of life for women with breast cancer. Breast Cancer Res Treat. 2005;93(3):217-26. https://doi.org/10.1007/s10549-005-5151-5
41. Beurskens CHG, van Uden CJT, Strobbe LJA, Oostendorp RAB, Wobbes T. The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study. BMC Cancer. 2007;7:166. https://doi.org/10.1186/1471-2407-7-166
42. Hasenoehrl T, Keilani M, Palma S, Crevenna R. Resistance exercise and breast cancer related lymphedema - a systematic review update. Disabil Rehabil. 2020;42(1):26-35. https://doi.org/10.1080/09638288.2018.1514663
43. Rangon FB, da Silva J, Dibai-Filho AV, Guirro RRJ, Guirro ECO. Effects of Complex Physical Therapy and multimodal approaches on lymphedema secondary to breast cancer: a systematic review and meta-analysis of randomized controlled trials. Arch Phys Med Rehabil. 2022;103(2):353-63. https://doi.org/10.1016/j.apmr.2021.06.027
44. Panchik D, Masco S, Zinnikas P, Hillriegel B, Lauder T, Suttmann E, et al. Effect of exercise on breast cancer-related lymphedema: what the lymphatic surgeon needs to know. J Reconstr Microsurg. 2019;35(1):37-45. https://doi.org/10.1055/s-0038-1660832
45. Serra-Añó P, Inglés M, Bou-Catalá C, Iraola-Lliso A, Espí-López GV. Effectiveness of myofascial release after breast cancer surgery in women undergoing conservative surgery and radiotherapy: a randomized controlled trial. Support Care Cancer. 2019;27(7):2633-41. https://doi.org/10.1007/s00520-018-4544-z
46. Bailey LB, Thigpen CA, Hawkins RJ, Beattie PF, Shanley E. Effectiveness of manual therapy and stretching for baseball players with shoulder range of motion deficits. Sports Health. 2017;9(3):230-7. https://doi.org/10.1177/1941738117702835
47. Novak CB, von der Heyde RL. Evidence and techniques in rehabilitation following nerve injuries. Hand Clinics. 2013;29(3):383-92. https://doi.org/10.1016/j.hcl.2013.04.012
48. Nogueira PVG. Efeitos da facilitação neuromuscular proprioceptiva na performance funcional de mulheres mastectomizadas. Fisioter Bras [Internet]. 2005 [cited 2022 Jun 1];6(1):28-35. Available from: https://bit.ly/3NP6zSs
49. INCA - Instituto Nacional de Câncer. Atividade Física [Internet]. 2021 [updated 2020 Apr 14; cited 2022 jun 1]. Available from: https://bit.ly/395Zm1r
50. Lahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies. Acta Oncol. 2015;54(5):635-54. https://doi.org/10.3109/0284186X.2014.998275
51. Farmer GD, Pearson M, Skylark WJ, Freeman ALJ, Spiegelhalter DJ. Redevelopment of the Predict: Breast Cancer website and recommendations for developing interfaces to support decision-making. Cancer Med. 2021;10(15):5141-53. https://doi.org/10.1002/cam4.4072
52. Box RC, Reul-Hirche HM, Bullock-Saxton JE, Furnival CM. Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema. Breast Cancer Res Treat. 2002;75(1):51-64. https://doi.org/10.1023/A:1016591121762
53. Lee MJ, Beith J, Ward L, Kilbreath S. Lymphedema following taxane-based chemotherapy in women with early breast cancer. Lymphat Res Biol. 2014;12(4):282-8. https://doi.org/10.1089/lrb.2014.0030
54. Saibil S, Fitzgerald B, Freedman OC, Amir E, Napolskikh J, Salvo N, et al. Incidence of taxane-induced pain and distress in patients receiving chemotherapy for early-stage breast cancer: a retrospective, outcomes-based survey. Curr Oncol 2010;17(4):42-7. https://doi.org/10.3747/co.v17i4.562
55. Vega MCMD, Laviano A, Pimentel GD. Sarcopenia e toxicidade mediada pela quimioterapia. Einstein (São Paulo). 2016;14:580-4. https://doi.org/10.1590/s1679-45082016md3740
56. Rodrigues TCR. Proposta de uma ficha de avaliação fisioterapêutica para pacientes mastectomizadas [Specialization Monograph]. Uberlância, MG: Universidade Federal de Uberlância; 2019 [cited 2022 Jun 1]. 49 p. Available from: https://repositorio.ufu.br/handle/123456789/24650